Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03534323 |
Title | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Dana-Farber Cancer Institute |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Miami- Sylvester Comprehensive Cancer Center | ACTIVE_NOT_RECRUITING | Miami | Florida | 33136 | United States | Details |
Northern Light Eastern Maine Medical Center | RECRUITING | Brewer | Maine | 04412 | United States | Details |
Massachusetts General Hospital | ACTIVE_NOT_RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
Boston Medical Center | COMPLETED | Boston | Massachusetts | 02118 | United States | Details |
Beth Israel Deaconess Medical Center | COMPLETED | Boston | Massachusetts | 02215 | United States | Details |
Dana Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Berkshire Medical Center | COMPLETED | Pittsfield | Massachusetts | 01201 | United States | Details |